These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6152857)

  • 1. Risk factors for the neuroleptic malignant syndrome.
    Kirkpatrick B; Edelsohn GA
    Psychiatr Med; 1984 Dec; 2(4):371-81. PubMed ID: 6152857
    [No Abstract]   [Full Text] [Related]  

  • 2. [Neuroleptic malignant syndrome--sequela of an individually relatively high neuroleptic dosage?].
    Bechter K
    Nervenarzt; 1997 Jul; 68(7):601. PubMed ID: 9333725
    [No Abstract]   [Full Text] [Related]  

  • 3. [Neuroleptic malignant syndrome. Case reports].
    Berardi D; Troia M; Veronesi L; Ferrari G
    Minerva Psichiatr; 1994 Dec; 35(4):199-219. PubMed ID: 7861943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catatonia and mild neuroleptic malignant syndrome after initiation of long-acting injectable risperidone: case report.
    Mall GD; Hake L; Benjamin AB; Adityanjee A
    J Clin Psychopharmacol; 2008 Oct; 28(5):572-3. PubMed ID: 18794658
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuroleptic malignant syndrome.
    Bhattacharyya K
    J Assoc Physicians India; 1999 Sep; 47(9):940. PubMed ID: 10778680
    [No Abstract]   [Full Text] [Related]  

  • 6. Adverse effects of summer amongst people with learning disabilities: neuroleptic malignant syndrome.
    Fitzgerald B; Middleton JK; Cooper SA
    J Intellect Disabil Res; 1997 Jun; 41 ( Pt 3)():273-7. PubMed ID: 9219078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The malignant neuroleptic syndrome].
    Pietzcker A
    Nervenarzt; 1988 Dec; 59(12):691-700. PubMed ID: 2905769
    [No Abstract]   [Full Text] [Related]  

  • 8. [Neuroleptic malignant syndrome in users of risperidone].
    Kroon JG
    Ned Tijdschr Geneeskd; 2005 Jan; 149(3):157-8; author reply 158. PubMed ID: 15693594
    [No Abstract]   [Full Text] [Related]  

  • 9. Neuroleptic malignant syndrome and mental retardation: review and analysis of 29 cases.
    Boyd RD
    Am J Ment Retard; 1993 Jul; 98(1):143-55. PubMed ID: 8103996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroleptic malignant syndrome.
    Mooney RP; Hasan MK
    W V Med J; 1990 Mar; 86(3):95-8. PubMed ID: 1969191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical neuroleptic malignant syndrome with long-term clozapine.
    Corallo CE; Ernest D
    Crit Care Resusc; 2007 Dec; 9(4):338-40. PubMed ID: 18052897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neuroleptic malignant syndrome--in need of acute care].
    Poutanen O; Kiviniemi P
    Duodecim; 2004; 120(2):163-8. PubMed ID: 15065507
    [No Abstract]   [Full Text] [Related]  

  • 13. Twenty neuroleptic rechallenges after neuroleptic malignant syndrome in 15 patients.
    Rosebush PI; Stewart TD; Gelenberg AJ
    J Clin Psychiatry; 1989 Aug; 50(8):295-8. PubMed ID: 2569457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
    Khaldi S; Kornreich C; Choubani Z; Gourevitch R
    Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protracted neuroleptic malignant syndrome complicating long-acting neuroleptic administration.
    Legras A; Hurel D; Dabrowski G; Grenet D; Graveleau P; Loirat P
    Am J Med; 1988 Dec; 85(6):875-8. PubMed ID: 2904226
    [No Abstract]   [Full Text] [Related]  

  • 16. Risk factors for neuroleptic malignant syndrome.
    Francis A; Chandragiri S; Petrides G
    Am J Psychiatry; 1998 Nov; 155(11):1639-40. PubMed ID: 9812151
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment.
    Ozen ME; Yumru M; Savas HA; Cansel N; Herken H
    World J Biol Psychiatry; 2007; 8(1):42-4. PubMed ID: 17366349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Case of neuroleptic malignant syndrome accompanied to an atypical antipsychotic agent: risperidone.
    Pasa S; Sayhan MB; Boyraz T; Urakci Z; Altintas A
    Neurotoxicology; 2008 Jul; 29(4):750-1. PubMed ID: 18539333
    [No Abstract]   [Full Text] [Related]  

  • 19. Neuroleptic malignant syndrome.
    Bristow MF; Kohen D
    Br J Hosp Med; 1996 Apr 17-30; 55(8):517-20. PubMed ID: 8732227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neuroleptic malignant syndrome: a review of literature].
    Crespo Facorro B; Carbonell Masia C
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1995; 23(5):273-8. PubMed ID: 8553925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.